Related Experiment Video

Updated: Jun 12, 2026

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)

Published on: April 7, 2021

['Acute respiratory distress syndrome' (ARDS) as a serious complication of influenza]

Pieter L A Fraaij1, Robert-Jan Houmes, Vincent M Geukers

  • 1Erasmus MC-Sophia, Afd. Kinder-intensive Care, Rotterdam, The Netherlands. p.fraaij@erasmusmc.nl

Nederlands Tijdschrift Voor Geneeskunde
|May 21, 2010
PubMed

Insights

Severe swine flu (H1N1) caused acute respiratory distress syndrome (ARDS) and septic shock in three children. Extracorporeal membrane oxygenation (ECMO) saved two lives, but one patient died due to instability.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Influenza A (H1N1), or swine flu, can lead to severe respiratory complications.
  • Acute respiratory distress syndrome (ARDS) is a life-threatening lung condition.
  • Pediatric cases of severe H1N1 infection require intensive monitoring and treatment.

Observation:

  • Three pediatric patients developed ARDS following H1N1 infection.
  • Two patients also experienced septic shock.
  • Standard intensive care unit (ICU) treatment, including mechanical ventilation, was insufficient for recovery.

Findings:

  • Extracorporeal membrane oxygenation (ECMO) facilitated recovery in two children with H1N1-induced ARDS.
  • One patient, too unstable for ECMO transfer, did not survive.
  • This highlights the critical role of advanced life support in severe pediatric H1N1 cases.

Implications:

  • ECMO may be a life-saving intervention for pediatric patients with severe H1N1 and ARDS.
  • Early identification and aggressive management are crucial for improving outcomes.
  • Further research into managing severe H1N1 complications in children is warranted.

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome06:06

Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome

Published on: October 26, 2018

Related Concept Videos

Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...